Home >
Research
Research
Over the past 27 years, the MacLab group, a shareholder
of Pharmalink International Limited, has employed the services of leading international
research individuals and institutions to identify and isolate the active components
within green lipped mussel. Today the fruits of that long term project are realised
in the product we know as Lyprinol ®
The studies below are in
PDF form and can be read online or downloaded
Human Studies
Animal Studies
Barnes, 2002, Asthma Resp Journal Random
Clinical . Borland, 1999, Immunomodulating Effect
of Lyprinol . Gibson, 1998, CTinM Arthritis Random Trial . Gibson, 2000, JA&CM Arthritis Three
Case Studies. James 1999, AJCN Inflammatory Mediators. Korea, 2002, NMJ Efficacy and Safety Study . Lau, 2004, PinN Lyprinol Osteo Arthritis
Clinical . Yemelyanov, 2000, Report Lyprinol Moderate
Asthma Trial .
Murphy, 2005, Tenikoff et al - J Gastroenterol_ Lyprinol
IBS Whitehouse & Rainsford, 1980, Arztnei_ Gastroprotective
Orig. Whitehouse Shiels, 2000_ Allergie et Immun Dysmenorrhoa Inf Whitehouse, 1997, IJ_ Inflammatory Study Lyprinol. Whitehouse, 2000, Internal pilot Study - Naproxen + Celebre. Whitehouse, 2001, Internal Lyprinol vs glycogen
Whitehouse,
2002, A&RJ Call for a Trial Letter.
Pharmalink International Limited. Pharmalink Marketing Australia Pty. Ltd. 19 Taree Streetpharma@plink.com.au
